Sg Americas Securities, LLC Galectin Therapeutics Inc Transaction History
Sg Americas Securities, LLC
- $24.4 Billion
- Q4 2024
A detailed history of Sg Americas Securities, LLC transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 13,935 shares of GALT stock, worth $16,164. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,935Holding current value
$16,164% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding GALT
# of Institutions
93Shares Held
9.73MCall Options Held
1.16MPut Options Held
1.98M-
Vanguard Group Inc Valley Forge, PA2.13MShares$2.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$1.81 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.18MShares$1.37 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA863KShares$1 Million0.0% of portfolio
-
Commonwealth Equity Services, LLC483KShares$560,5860.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $68.9M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...